360 related articles for article (PubMed ID: 16981935)
1. Posttransplant lymphoproliferative disorder: a pictorial review.
Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
[TBL] [Abstract][Full Text] [Related]
2. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.
Scarsbrook AF; Warakaulle DR; Dattani M; Traill Z
Clin Radiol; 2005 Jan; 60(1):47-55. PubMed ID: 15642292
[TBL] [Abstract][Full Text] [Related]
3. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ
Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
[TBL] [Abstract][Full Text] [Related]
4. Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation.
Borhani AA; Hosseinzadeh K; Almusa O; Furlan A; Nalesnik M
Radiographics; 2009; 29(4):981-1000; discussion 1000-2. PubMed ID: 19605652
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorder: a review.
Loren AW; Porter DL; Stadtmauer EA; Tsai DE
Bone Marrow Transplant; 2003 Feb; 31(3):145-55. PubMed ID: 12621474
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines.
Parker A; Bowles K; Bradley JA; Emery V; Featherstone C; Gupte G; Marcus R; Parameshwar J; Ramsay A; Newstead C;
Br J Haematol; 2010 Jun; 149(5):675-92. PubMed ID: 20408847
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.
Preiksaitis JK; Keay S
Clin Infect Dis; 2001 Jul; 33 Suppl 1():S38-46. PubMed ID: 11389521
[TBL] [Abstract][Full Text] [Related]
8. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
Lee JJ; Lam MS; Rosenberg A
Ann Pharmacother; 2007 Oct; 41(10):1648-59. PubMed ID: 17848421
[TBL] [Abstract][Full Text] [Related]
9. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant lymphoproliferative disorder.
Everly MJ; Bloom RD; Tsai DE; Trofe J
Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
13. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients.
Preiksaitis JK
Clin Infect Dis; 2004 Oct; 39(7):1016-23. PubMed ID: 15472855
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
[TBL] [Abstract][Full Text] [Related]
15. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
Ghobrial IM; Habermann TM; Maurer MJ; Geyer SM; Ristow KM; Larson TS; Walker RC; Ansell SM; Macon WR; Gores GG; Stegall MD; McGregor CG
J Clin Oncol; 2005 Oct; 23(30):7574-82. PubMed ID: 16186599
[TBL] [Abstract][Full Text] [Related]
16. Classification of the posttransplant lymphoproliferative disorders: from the past to the present.
Swerdlow SH
Semin Diagn Pathol; 1997 Feb; 14(1):2-7. PubMed ID: 9044504
[TBL] [Abstract][Full Text] [Related]
17. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-pathological analysis of 6 cases of post-transplant lymphoproliferative disorders].
Wang ZM; Zheng SS; Ding W; Wang LJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):514-8. PubMed ID: 18078125
[TBL] [Abstract][Full Text] [Related]
19. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
Svoboda J; Kotloff R; Tsai DE
Transpl Int; 2006 Apr; 19(4):259-69. PubMed ID: 16573540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
